Janux Therapeutics, Inc. SEC filings JANX

Janux Therapeutics, Inc. has 442 filings in SEC EDGAR's recent list, going back to Jul 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Janux Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 31, 2026 Jul 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
4 Insider transaction Jul 10, 2026 Jul 8, 2026
8-K Current report
Other events
Jun 23, 2026 Jun 23, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
144 Notice of proposed sale Jun 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 13, 2026 May 11, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
8-K Current report
Officer or director change
Apr 28, 2026 Apr 28, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
144 Notice of proposed sale Apr 13, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 6, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
3 Initial insider ownership Feb 4, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 26, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jan 22, 2026 Jan 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Nov 14, 2025 Nov 14, 2025
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
144 Notice of proposed sale Oct 28, 2025 —
8-K Current report
Officer or director change
Sep 19, 2025 Sep 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
3 Initial insider ownership May 23, 2025 May 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
4 Insider transaction May 2, 2025 May 1, 2025
144 Notice of proposed sale May 1, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Apr 25, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
4 Insider transaction Apr 23, 2025 Apr 21, 2025
144 Notice of proposed sale Apr 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 10, 2025 —
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 3, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
144 Notice of proposed sale Feb 3, 2025 —
4 Insider transaction Jan 8, 2025 Jan 7, 2025
144 Notice of proposed sale Jan 7, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
3/A Filing Jan 3, 2025 Jan 1, 2023
3 Initial insider ownership Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 2, 2025 —
4 Insider transaction Dec 27, 2024 Dec 24, 2024
144 Notice of proposed sale Dec 26, 2024 —
4 Insider transaction Dec 20, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 5, 2024 Dec 4, 2024
424B5 Prospectus supplement Dec 5, 2024 —
4 Insider transaction Dec 3, 2024 Dec 3, 2024
424B5 Prospectus supplement Dec 3, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 2, 2024 Dec 2, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 8, 2024 —
4 Insider transaction Nov 7, 2024 Nov 5, 2024
4 Insider transaction Nov 7, 2024 Nov 5, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
144 Notice of proposed sale Nov 1, 2024 —
4 Insider transaction Oct 30, 2024 Oct 28, 2024
144 Notice of proposed sale Oct 28, 2024 —
144 Notice of proposed sale Oct 28, 2024 —
144 Notice of proposed sale Oct 28, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 25, 2024 —
144 Notice of proposed sale Oct 25, 2024 —
144 Notice of proposed sale Oct 25, 2024 —
144 Notice of proposed sale Oct 25, 2024 —
144/A Filing Oct 25, 2024 —
144 Notice of proposed sale Oct 24, 2024 —
144 Notice of proposed sale Oct 24, 2024 —
4 Insider transaction Oct 24, 2024 Sep 13, 2024
144 Notice of proposed sale Oct 23, 2024 —
SC 13G Ownership over 5% (passive) Oct 23, 2024 —
144 Notice of proposed sale Oct 23, 2024 —
144 Notice of proposed sale Oct 23, 2024 —
144 Notice of proposed sale Oct 23, 2024 —
4 Insider transaction Oct 22, 2024 Oct 18, 2024
SC 13D/A Amended ownership over 5% (active) Oct 22, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 22, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
4 Insider transaction Oct 18, 2024 Oct 16, 2024
144 Notice of proposed sale Oct 18, 2024 —
144 Notice of proposed sale Oct 18, 2024 —
144 Notice of proposed sale Oct 18, 2024 —
144 Notice of proposed sale Oct 17, 2024 —
144 Notice of proposed sale Oct 17, 2024 —
144 Notice of proposed sale Oct 17, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
4 Insider transaction Sep 30, 2024 Sep 26, 2024
144 Notice of proposed sale Sep 30, 2024 —
144 Notice of proposed sale Sep 30, 2024 —
144 Notice of proposed sale Sep 30, 2024 —
4 Insider transaction Sep 27, 2024 Sep 27, 2024
4 Insider transaction Sep 27, 2024 Sep 27, 2024
4 Insider transaction Sep 27, 2024 Sep 27, 2024
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 26, 2024 —
144 Notice of proposed sale Sep 26, 2024 —
144 Notice of proposed sale Sep 26, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 16, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 16, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
JANX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1817713

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.